Literature DB >> 18930321

Deferasirox plus ciprofloxacin combination therapy after rapid diagnosis of Vibrio vulnificus sepsis using real-time polymerase chain reaction.

Dong-Min Kim1, Hong Sung Cho, Ji-In Kang, Hyong Sun Kim, Chi Young Park.   

Abstract

We report a case of Vibrio vulnificus sepsis developed during deferoxamine therapy for transfusional iron overload due to secondary hemochromatosis of myelodysplastic syndrome. The patient was treated with adjuvant deferasirox in combination with ciprofloxacin, after rapid diagnosis of V. vulnificus sepsis using real-time polymerase chain reaction (PCR). This case suggests that since V. vulnificus DNA can be detected by real-time PCR for several days even after patients receive antibiotics, real-time PCR for V. vulnificus is a very useful test for establishing an early diagnosis, even if a patient has been treated with antibiotics prior to admission.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18930321     DOI: 10.1016/j.jinf.2008.08.003

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  2 in total

1.  In vitro time-kill activities of ciprofloxacin alone and in combination with the iron chelator deferasirox against Vibrio vulnificus.

Authors:  G P Neupane; D-M Kim
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-02-02       Impact factor: 3.267

2.  In vivo efficacy of the combination of ciprofloxacin and cefotaxime against Vibrio vulnificus sepsis.

Authors:  Hee-Chang Jang; Su-Mi Choi; Hee Kyung Kim; Sung-Eun Kim; Seung-Ji Kang; Kyung-Hwa Park; Phil Youl Ryu; Tae-Hoon Lee; Young Ran Kim; Joon Haeng Rhee; Sook-In Jung; Hyon E Choy
Journal:  PLoS One       Date:  2014-06-30       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.